Morishita Jintan Co., Ltd. (4524.T)

JPY 2065.0

(0.05%)

Gross Profit Summary of Morishita Jintan Co., Ltd.

  • Morishita Jintan Co., Ltd.'s latest annual gross profit in 2023 was 5.99 Billion JPY , up 12.91% from previous year.
  • Morishita Jintan Co., Ltd.'s latest quarterly gross profit in 2024 Q1 was 1.53 Billion JPY , up 13.91% from previous quarter.
  • Morishita Jintan Co., Ltd. reported a annual gross profit of 5.31 Billion JPY in annual gross profit 2022, up 8.92% from previous year.
  • Morishita Jintan Co., Ltd. reported a annual gross profit of 4.87 Billion JPY in annual gross profit 2021, up 1.9% from previous year.
  • Morishita Jintan Co., Ltd. reported a quarterly gross profit of 1.54 Billion JPY for 2023 Q3, down -2.21% from previous quarter.
  • Morishita Jintan Co., Ltd. reported a quarterly gross profit of 1.58 Billion JPY for 2023 Q2, up 4.14% from previous quarter.

Annual Gross Profit Chart of Morishita Jintan Co., Ltd. (2023 - 2019)

Historical Annual Gross Profit of Morishita Jintan Co., Ltd. (2023 - 2019)

Year Gross Profit Gross Profit Growth
2023 5.99 Billion JPY 12.91%
2022 5.31 Billion JPY 8.92%
2021 4.87 Billion JPY 1.9%
2020 4.78 Billion JPY -2.78%
2019 4.92 Billion JPY 0.0%

Peer Gross Profit Comparison of Morishita Jintan Co., Ltd.

Name Gross Profit Gross Profit Difference
Pharma Foods International Co., Ltd. 48.75 Billion JPY 87.697%
Takeda Pharmaceutical Company Limited 2184.96 Billion JPY 99.725%
Sumitomo Pharma Co., Ltd. 187.98 Billion JPY 96.809%
Shionogi & Co., Ltd. 369.08 Billion JPY 98.375%
Wakamoto Pharmaceutical Co.,Ltd. 3.54 Billion JPY -69.394%
Nippon Shinyaku Co., Ltd. 97.01 Billion JPY 93.818%
Kaken Pharmaceutical Co., Ltd. 38.22 Billion JPY 84.307%
Eisai Co., Ltd. 586.41 Billion JPY 98.977%
Hisamitsu Pharmaceutical Co., Inc. 78.97 Billion JPY 92.405%
Mochida Pharmaceutical Co., Ltd. 52.07 Billion JPY 88.481%
Fuso Pharmaceutical Industries,Ltd. 13.51 Billion JPY 55.626%
Nippon Chemiphar Co., Ltd. 7.73 Billion JPY 22.486%
Tsumura & Co. 68.81 Billion JPY 91.284%
Kissei Pharmaceutical Co., Ltd. 37.34 Billion JPY 83.937%
Torii Pharmaceutical Co., Ltd. 24.79 Billion JPY 75.807%
Towa Pharmaceutical Co., Ltd. 81.38 Billion JPY 92.63%
Fuji Pharma Co., Ltd. 16.51 Billion JPY 63.682%
Zeria Pharmaceutical Co., Ltd. 50.18 Billion JPY 88.047%
KYORIN Holdings, Inc. 51.4 Billion JPY 88.331%
Taiko Pharmaceutical Co.,Ltd. 1.07 Billion JPY -455.885%
Daito Pharmaceutical Co.,Ltd. 9.83 Billion JPY 39.039%
SymBio Pharmaceuticals Limited 4.41 Billion JPY -35.978%
MedRx Co., Ltd 26 Million JPY -22969.231%
Mizuho Medy Co.,Ltd. 8.02 Billion JPY 25.265%
Solasia Pharma K.K. 337 Million JPY -1679.822%
Modalis Therapeutics Corporation -731 Thousand JPY 820619.836%
ASKA Pharmaceutical Holdings Co.,Ltd. 30.66 Billion JPY 80.44%
Sawai Group Holdings Co., Ltd. 54.31 Billion JPY 88.958%
Cyfuse Biomedical K.K. 37.74 Million JPY -15791.267%
Toho Holdings Co., Ltd. 112.98 Billion JPY 94.691%
Koa Shoji Holdings Co.,Ltd. 6.63 Billion JPY 9.663%